SCHEMBL16782981

SCHEMBL16782981

COc1cc(OC(F)F)ncc1-c1cc(C(=O)Nc2c(F)cncc2F)nn1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 2/20 0.37
▸ ORAI1 Q96D31 2/20 0.37
▸ PDE4D Q08499 6/20 0.35
▸ PDE4B Q07343 5/20 0.35
▸ PDE4A P27815 3/20 0.35
▸ PDE4C Q08493 3/20 0.35
▸ ABCB11 O95342 1/20 0.33
▸ FPR2 P25090 3/20 0.33
▸ FPR1 P21462 2/20 0.33
▸ POLQ O75417 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ RORC P51449 2/20 0.33
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16783052 0.92 PDE4D (0.42) PDE4DPDE4BPDE4APDE4CFPR2
SCHEMBL16783055 0.91 STIM1 (0.39) STIM1ORAI1PDE4DPDE4BPDE4A
SCHEMBL16783092 0.88 NPC1 (0.39) STIM1ORAI1PDE4DPDE4BPDE4A
SCHEMBL16804980 0.83 CRHR1 (0.36) POLQMEN1ALDH1A1LMNAMAPT
SCHEMBL16783082 0.83 PDE4D (0.46) ORAI1PDE4DPDE4BPDE4APDE4C
SCHEMBL16783020 0.82 PDE4B (0.40) STIM1ORAI1PDE4DPDE4BPDE4A
SCHEMBL16783019 0.82 NPC1 (0.40) STIM1ORAI1ALDH1A1MAPTNPC1
SCHEMBL16804963 0.82 ORAI1 (0.39) STIM1ORAI1PDE4DPDE4BPDE4A
SCHEMBL16856692 0.81 DHODH (0.34) ORAI1PDE4DGAAMEN1ALDH1A1
SCHEMBL16783093 0.81 NPC1 (0.39) STIM1ORAI1POLQMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US claimed
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 — — WO disclosed
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 — — WO disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES AADAC, NLRP3, NOD2 STIM1 1469/4885ORAI1 2913/4885PDE4D 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback